Analyzing key genetic and comorbid factors on the efficacy of digital therapeutics for treating high blood pressure-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Analyzing key genetic and comorbid factors on the efficacy of digital therapeutics for treating high blood pressure

Published:2024-02-28 Issue:2 Volume:29 Page:107-108
ISSN:1359-5237
Container-title:Blood Pressure Monitoring
language:en
Short-container-title:

Author:

Patel Jigar¹²,Zia Hasan²³,Lo David F.¹²³⁴

Affiliation:

1. Department of Medicine, Rowan University School of Osteopathic Medicine

2. American Preventive Screening & Education Association (APSEA), Stratford

3. Department of Biology, Rutgers, the State University of New Jersey, New Brunswick

4. Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference4 articles.

1. Real-world long-term effects on blood pressure and other cardiovascular risk factors for patients in digital therapeutics [published online ahead of print, 2022 Dec 7].;Willis;Blood Press Monit,2022

2. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus.;Iglay;Curr Med Res Opin,2016

3. Combinations in the treatment of hypertension: ACE inhibitors and calcium antagonists.;Messerli;Am J Hypertens,1999

4. The association between antidepressant use and orthostatic hypotension in older people: a matched cohort study.;Briggs;J Am Soc Hypertens,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP